CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 7237-7470 JSONTXT

{"project":"CORD-PICO","denotations":[{"id":"p1_all61","span":{"begin":43,"end":80},"obj":"Outcome"},{"id":"p1_all62","span":{"begin":104,"end":120},"obj":"Intervention"},{"id":"p1_all63","span":{"begin":174,"end":233},"obj":"Population"},{"id":"p2_p2","span":{"begin":193,"end":232},"obj":"Condition"},{"id":"p2_i28","span":{"begin":104,"end":120},"obj":"Pharmacological"},{"id":"p2_o48","span":{"begin":43,"end":57},"obj":"Mortality"}],"text":"The purpose of this study was to determine survival times and complication rates for dogs who underwent transve-Atenolol is a β 1 -receptor antagonist commonly prescribed in cats affected with hypertrophic obstructive cardiomyopathy."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T51","span":{"begin":0,"end":233},"obj":"Sentence"},{"id":"T44988","span":{"begin":0,"end":233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The purpose of this study was to determine survival times and complication rates for dogs who underwent transve-Atenolol is a β 1 -receptor antagonist commonly prescribed in cats affected with hypertrophic obstructive cardiomyopathy."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T22","span":{"begin":193,"end":232},"obj":"Disease"},{"id":"T23","span":{"begin":218,"end":232},"obj":"Disease"},{"id":"T9455","span":{"begin":193,"end":232},"obj":"Disease"},{"id":"T9871","span":{"begin":218,"end":232},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005045"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"},{"id":"A23693","pred":"mondo_id","subj":"T9455","obj":"http://purl.obolibrary.org/obo/MONDO_0005045"},{"id":"A63205","pred":"mondo_id","subj":"T9871","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"}],"text":"The purpose of this study was to determine survival times and complication rates for dogs who underwent transve-Atenolol is a β 1 -receptor antagonist commonly prescribed in cats affected with hypertrophic obstructive cardiomyopathy."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T11","span":{"begin":218,"end":232},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0001638"}],"text":"The purpose of this study was to determine survival times and complication rates for dogs who underwent transve-Atenolol is a β 1 -receptor antagonist commonly prescribed in cats affected with hypertrophic obstructive cardiomyopathy."}